PATENT CLAIM ANALYSIS

Application Number: 15768609
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "062000"]

Abstract:
A skin whitening composition includes amorphigeni or a salt thereof as an effective ingredient. Amorphigeni suppresses the expression of tyrosinase and induces autophagy on melanosomes. As such, it was confirmed that amorphigeni not only suppresses melanin production but also exhibits the effect of removing melanin previously produced by α-MSH (melanocyte-stimulating hormone). Accordingly, amorphigeni can be advantageously used as a functional material for skin whitening and skin lightening.

Claim (Index 24):
The method of  claim 23 , wherein the melanin hyperpigmentation disorder is freckles, senile spots, chloasma, small brown spots, brown or black moles, sunshine pigment spots, cyanic melisma, hyperpigmentation after drug use, gravidic chloasma, or hyperpigmentation after inflammation caused by lesions or skin inflammation like excoriation and burn.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.27119
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15739894', '15113692', '13462287', '12848380', '16305492']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.754688241762934
- 35 USC 102 Novelty (BERT): 0.5238202833859714
- Combined Prediction Score: 0.7316014459252378
- Mean Citation Score: 263.733836
- Max Citation Score: 275.54672
- Similarity Product: 141.67754249357222

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test